Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case-control study

doi:10.1136/bmjopen-2017-019868

CNU IR > College of Sustainable Environment and Recreation > Dept. of Sports Management > Periodical Articles > Item 310902800/32174

Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/32174

Title:	Second-generation antipsychotic medications and risk of chronic kidney disease in schizophrenia: population-based nested case-control study
Authors:	Wang, Hsien-Yi Huang, Charles Lung-Cheng Feng, I. Jung Tsuang, Hui-Chun
Contributors:	Chi Mei Med Ctr, Div Nephrol Chia Nan Univ Pharm & Sci, Coll Leisure & Recreat Management, Dept Sport Management Chi Mei Med Ctr, Div Psychiat Chia Nan Univ Pharm & Sci, Dept Social Work Chi Mei Med Ctr, Dept Med Res Chang Jung Christian Univ, Ctr Gen Educ
Keywords:	New-Generation Antipsychotics Quality-Of-Life Atypical Antipsychotics Mood Stabilizers Mortality Taiwan Cohort Epidemiology Metaanalysis Prevalence
Date:	2018-05
Issue Date:	2019-11-15 15:43:46 (UTC+8)
Publisher:	BMJ PUBLISHING GROUP
Abstract:	Objectives The study aims to compare the risk of chronic kidney diseases (CKDs) between patients with schizophrenia using first and second-generation antipsychotics. Setting Datasets of 2000-2013 National Health Insurance in Taiwan were used. Participants The National Health Insurance reimbursement claims data have been transferred to and managed by the National Health Research Institute in Taiwan since 1996. We used the Psychiatric Inpatient Medical Claims database, a subset of the National Health Insurance Research Database, comprising a cohort of patients hospitalised for psychiatric disorders between 2000 and 2013 (n=267807). The database included patients with at least one psychiatric inpatient record and one discharge diagnosis of mental disorders coded by the International Classification of Diseases, Ninth Revision (ICD-9) codes 290-319. The age of patients at first admission was restricted to 18-65 years. Primary outcome CKD (ICD-9 code 582, 583, 585, 586, 588) requiring hospitalisation or three outpatient visits. The diagnosis of CKD follows the criteria of 'Kidney Disease: Improving Global Outcomes' in Taiwan. CKD is defined as a kidney damage as albumin-to-creatinine ratio >30 mg/g in two of three spot urine specimens or glomerular filtration rate <60 mUmin/1.73 m(2) for 3 months or more. Results We found that the risks for CKD were higher for those who used second-generation antipsychotics (SGAs) longer cumulatively than those who did not. Using nonusers, patients did not have any SGA records, as reference group, the risks for CKD comparing those using SGAs for 90 to 180 days with non-users and those using SGAs for more than 1000 days were 1.42 (1.06-1.91) and 1.30 (1.13-1.51), respectively. Conclusions The current study suggests the relationship between using SGAs and risk of CKD.
???metadata.dc.relation.uri???:	http://dx.doi.org/10.1136/bmjopen-2017-019868
Relation:	Journal of Electronic Commerce Research, v.8, n.5, e019868
Appears in Collections:	[Dept. of Sports Management] Periodical Articles [Dept. of Social Work] Periodical Articles

Files in This Item:

File	Description	Size	Format
10.1136-bmjopen-2017-019868.pdf		220Kb	Adobe PDF	493	View/Open
index.html		0Kb	HTML	1698	View/Open

Loading...